Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary care
Matthew J. Carr, Alison K. Wright, Lalantha Leelarathna, Hood Thabit, Nicola Milne, Naresh Kanumilli, Darren M. Ashcroft, Martin K. Rutter
doi: https://doi.org/10.1101/2021.04.21.21255869
Matthew J. Carr
1Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK
2Manchester Academic Health Science Centre
3NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, UK
Alison K. Wright
1Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK
2Manchester Academic Health Science Centre
4Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Lalantha Leelarathna
2Manchester Academic Health Science Centre
4Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
5Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK
Hood Thabit
2Manchester Academic Health Science Centre
4Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
5Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK
Nicola Milne
2Manchester Academic Health Science Centre
5Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK
Naresh Kanumilli
2Manchester Academic Health Science Centre
5Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK
Darren M. Ashcroft
1Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK
2Manchester Academic Health Science Centre
3NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, UK
Martin K. Rutter
2Manchester Academic Health Science Centre
4Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
5Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester, UK
Data Availability
All clinical codes used in the study are published on Clinicalcodes.org. Electronic health records are, by definition, considered sensitive data in the UK by the Data Protection Act and cannot be shared via public deposition because of information governance restriction in place to protect patient confidentiality. Access to data are available only once approval has been obtained through the individual constituent entities controlling access to the data. The primary care data can be requested via application to the Clinical Practice Research Datalink (www.cprd.com).
Posted April 22, 2021.
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary care
Matthew J. Carr, Alison K. Wright, Lalantha Leelarathna, Hood Thabit, Nicola Milne, Naresh Kanumilli, Darren M. Ashcroft, Martin K. Rutter
medRxiv 2021.04.21.21255869; doi: https://doi.org/10.1101/2021.04.21.21255869
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary care
Matthew J. Carr, Alison K. Wright, Lalantha Leelarathna, Hood Thabit, Nicola Milne, Naresh Kanumilli, Darren M. Ashcroft, Martin K. Rutter
medRxiv 2021.04.21.21255869; doi: https://doi.org/10.1101/2021.04.21.21255869
Subject Areas
- Addiction Medicine (359)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2702)
- Dermatology (231)
- Emergency Medicine (408)
- Epidemiology (12343)
- Forensic Medicine (10)
- Gastroenterology (774)
- Genetic and Genomic Medicine (4188)
- Geriatric Medicine (394)
- Health Economics (691)
- Health Informatics (2708)
- Health Policy (1012)
- Hematology (366)
- HIV/AIDS (869)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (447)
- Neurology (3974)
- Nursing (216)
- Nutrition (587)
- Oncology (2093)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1137)
- Primary Care Research (464)
- Public and Global Health (6603)
- Radiology and Imaging (1432)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)